Literature DB >> 17376925

Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.

Matthieu Blanchet1, Camille Sureau.   

Abstract

The N-terminal pre-S domain of the large hepatitis B virus (HBV) envelope protein plays a pivotal role at the initial step of the viral entry pathway. In the present study, the entire pre-S domain was mapped for infectivity determinants, following a reverse-genetics approach and using in vitro infection assays with hepatitis delta virus (HDV) or HBV particles. The results demonstrate that lesions created within the N-terminal 75 amino acids of the pre-S region abrogate infectivity, whereas mutations between amino acids 76 and 113, overlapping the matrix domain, had no effect. In contrast to the results of a recent study (L. Stoeckl, A. Funk, A. Kopitzki, B. Brandenburg, S. Oess, H. Will, H. Sirma, and E. Hildt, Proc. Natl. Acad. Sci. 103:6730-6734, 2006), the deletion of a cell membrane translocation motif (TLM) located between amino acids 148 and 161 at the C terminus of pre-S2 did not interfere with the infectivity of the resulting HDV or HBV mutants. Furthermore, a series of large deletions overlapping the pre-S2 domain were compatible with infectivity, although the efficiency of infection was reduced when the deletions extended to the pre-S1 domain. Overall, the results demonstrate that the activity of the pre-S domain at viral entry solely depends on the integrity of its first 75 amino acids and thus excludes any function of the matrix domain or TLM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376925      PMCID: PMC1900317          DOI: 10.1128/JVI.00096-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus.

Authors:  C Sureau; B Guerra; H Lee
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

2.  Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis.

Authors:  V Bruss; K Vieluf
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.

Authors:  X Lu; T M Block; W H Gerlich
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Prediction of a putative fusion peptide in the S protein of hepatitis B virus.

Authors:  I Rodríguez-Crespo; J Gómez-Gutiérrez; M Nieto; D L Peterson; F Gavilanes
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

5.  Phospholipid interactions of the putative fusion peptide of hepatitis B virus surface antigen S protein.

Authors:  I Rodríguez-Crespo; E Núñez; J Gómez-Gutiérrez; B Yélamos; J P Albar; D L Peterson; F Gavilanes
Journal:  J Gen Virol       Date:  1995-02       Impact factor: 3.891

6.  The role of envelope proteins in hepatitis B virus assembly.

Authors:  V Bruss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

7.  Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.

Authors:  P Gripon; J Le Seyec; S Rumin; C Guguen-Guillouzo
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

8.  Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.

Authors:  V Bruss; J Hagelstein; E Gerhardt; P R Galle
Journal:  Virology       Date:  1996-04-15       Impact factor: 3.616

9.  Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein.

Authors:  V Bruss; X Lu; R Thomssen; W H Gerlich
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

10.  Novel transmembrane topology of the hepatitis B virus envelope proteins.

Authors:  R Prange; R E Streeck
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

View more
  52 in total

Review 1.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

2.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

Review 3.  Molecular biology of hepatitis B virus infection.

Authors:  Christoph Seeger; William S Mason
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

4.  HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.

Authors:  Hanjie Li; Qiuyu Zhuang; Yuze Wang; Tianying Zhang; Jinghua Zhao; Yali Zhang; Junfang Zhang; Yi Lin; Quan Yuan; Ningshao Xia; Jiahuai Han
Journal:  Cell Mol Immunol       Date:  2014-02-10       Impact factor: 11.530

5.  Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Authors:  Andreas Schulze; Alexa Schieck; Yi Ni; Walter Mier; Stephan Urban
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

Review 6.  Therapy of Delta Hepatitis.

Authors:  Cihan Yurdaydin; Ramazan Idilman
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-07       Impact factor: 6.915

7.  The translocation motif of hepatitis B virus envelope proteins is dispensable for infectivity.

Authors:  Charlotte Lepère; Morgane Régeard; Jacques Le Seyec; Philippe Gripon
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

8.  Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.

Authors:  Huan Yan; Bo Peng; Wenhui He; Guocai Zhong; Yonghe Qi; Bijie Ren; Zhenchao Gao; Zhiyi Jing; Mei Song; Guangwei Xu; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

9.  Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.

Authors:  Guocai Zhong; Huan Yan; Haimin Wang; Wenhui He; Zhiyi Jing; Yonghe Qi; Liran Fu; Zhenchao Gao; Yi Huang; Guangwei Xu; Xiaofeng Feng; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

10.  Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.

Authors:  Georges Abou-Jaoudé; Camille Sureau
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.